Jesse A. Berlin
Johnson & Johnson Pharmaceutical Research and Development
37 Papers
4.8K Citations
Jesse A. Berlin is an academic researcher from Johnson & Johnson Pharmaceutical Research and Development. The author has contributed to research in topics: Medicine & Odds ratio. The author has an hindex of 21, co-authored 37 publications. Previous affiliations of Jesse A. Berlin include Hospital of the University of Pennsylvania & University of Medicine and Dentistry of New Jersey.
Chat about Author
Papers
•Journal Article
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement [in Spanish]
David Moher,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman test,Gerd Antes,David C. Atkins,Virginia Barbour,N Barrowman,Jesse A. Berlin,J Clark,Mike Clarke,Deborah J. Cook,Roberto D'Amico,Jonathan J Deeks,Philip J. Devereaux,Kay Dickersin,M Egger,E Ernst,P C Gøtzsche,Jeremy M. Grimshaw,G Guyatt,Julian P T Higgins,Ioannidis Jpa.,Jos Kleijnen,Tom Lang,N Magrini,D McNamee,Lorenzo Moja,C Mulrow,M Napoli,Andrew D Oxman,B Pham,Drummond Rennie,Margaret Sampson,Kenneth F. Schulz,Paul G. Shekelle,David Tovey,Peter Tugwell +37 more
TL;DR: Higher quality, large, multicenter RCTs are needed to demonstrate the preventive effect of the two acid-suppressive drugs, PPIs were superior to H2RAs for prevention of LDA-related GI erosion/ulcer and bleeding.
34.2K
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (Chinese edition)
David Moher,Alessandro Liberati,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman test,Gerd Antes,David C. Atkins,Virginia Barbour,N Barrowman,Jesse A. Berlin,J Clark,Mike Clarke,Mike Clarke,Deborah J. Cook,Roberto D'Amico,Roberto D'Amico,Jonathan J Deeks,Philip J. Devereaux,Kay Dickersin,M Egger,E Ernst,P C Gøtzsche,Jeremy M. Grimshaw,G Guyatt,Julian P T Higgins,Ioannidis Jpa.,Jos Kleijnen,Tom Lang,N Magrini,D McNamee,Lorenzo Moja,C Mulrow,M Napoli,A Oxman,B Pham,Drummond Rennie,Margaret Sampson,K F Schulz,P G Shekelle,David Tovey,Peter Tugwell +40 more
TL;DR: Provide a structured summary including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings, systematic review registration number 2.
6.2K
•Journal Article
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher,A. Liberati,Jennifer Tetzlaff,Douglas G. Altman test,Gerd Antes,David C. Atkins,Virginia Barbour,Nick Barrowman,Jesse A. Berlin,Jocalyn Clark,Mike Clarke,Deborah J. Cook,Roberto D'Amico,Jonathan J Deeks,Philip J. Devereaux,Kay Dickersin,Matthias Egger,E Ernst,Peter C. Gøtzsche,Jeremy M. Grimshaw,G. H. Guyatt,Julian P T Higgins,Ioannidis Jpa.,Jos Kleijnen,Tom Lang,Nicola Magrini,D McNamee,Lorenzo Moja,Cynthia D. Mulrow,Maryann Napoli,Andrew D Oxman,B Pham,Drummond Rennie,Margaret Sampson,Kenneth F. Schulz,Paul G. Shekelle,David Tovey,Peter Tugwell +37 more
TL;DR: The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) as discussed by the authors is an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses.
4.5K
Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion
TL;DR: In this article, a retrospective cohort study of patients who declined RBC transfusions for religious reasons was performed, and the risk of death was low in patients with postoperative Hb levels of 7.1 to 8.0 g per dL, although morbidity occurred in 9.4 percent.
547
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials
K F Schulz,Douglas G. Altman test,David Moher,David Moher,Virginia Barbour,Jesse A. Berlin,Isabelle Boutron,Philip J. Devereaux,Kay Dickersin,Diana Elbourne,Susan S. Ellenberg,Val Gebski,Steven N. Goodman,Peter C Gøtzsche,Trish Groves,S Grunberg,Brian Haynes,Sally Hopewell,A James,P Juhn,Philippa Middleton,D Minckler,Victor M. Montori,Cynthia D. Mulrow,Stuart J. Pocock,Drummond Rennie,David L. Schriger,Iveta Simera,Elizabeth Wager +28 more
TL;DR: R controlled trials, when appropriately designed, conducted, and reported, represent the gold standard in evaluating healthcare interventions, however, randomized trials can yield biased results if they lack methodological rigour.